These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2452516)

  • 1. Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A.
    Uehara Y; Murakami Y; Mizuno S; Kawai S
    Virology; 1988 May; 164(1):294-8. PubMed ID: 2452516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS.
    Auvinen M; Paasinen-Sohns A; Hirai H; Andersson LC; Hölttä E
    Mol Cell Biol; 1995 Dec; 15(12):6513-25. PubMed ID: 8524216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro.
    Fukazawa H; Li PM; Yamamoto C; Murakami Y; Mizuno S; Uehara Y
    Biochem Pharmacol; 1991 Oct; 42(9):1661-71. PubMed ID: 1656993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase.
    Uehara Y; Hori M; Takeuchi T; Umezawa H
    Jpn J Cancer Res; 1985 Aug; 76(8):672-5. PubMed ID: 3930444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds.
    Uehara Y; Fukazawa H; Murakami Y; Mizuno S
    Biochem Biophys Res Commun; 1989 Sep; 163(2):803-9. PubMed ID: 2783121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A host-dependent temperature-sensitive mutant of Rous sarcoma virus: evidence for host factors affecting transformation.
    Young JC; Liebl E; Martin GS
    Virology; 1988 Oct; 166(2):561-72. PubMed ID: 2845662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for direct modification of NF kappa B by the tyrosine kinase inhibitor, herbimycin A.
    Mahon TM; O'Neill LA
    Biochem Soc Trans; 1995 Feb; 23(1):111S. PubMed ID: 7538940
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.
    Uehara Y; Murakami Y; Sugimoto Y; Mizuno S
    Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine.
    Kamps MP; Sefton BM
    Oncogene; 1988 Apr; 2(4):305-15. PubMed ID: 2452398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells.
    Mandanas RA; Leibowitz DS; Gharehbaghi K; Tauchi T; Burgess GS; Miyazawa K; Jayaram HN; Boswell HS
    Blood; 1993 Sep; 82(6):1838-47. PubMed ID: 7691239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes.
    Murakami Y; Uehara Y; Yamamoto C; Fukazawa H; Mizuno S
    Exp Cell Res; 1991 Aug; 195(2):338-44. PubMed ID: 2070817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of herbimycin A, an inhibitor of tyrosine kinase, on protein tyrosine kinase activity and phosphotyrosyl proteins of Ph1-positive leukemia cells.
    Okabe M; Kawamura K; Miyagishima T; Itaya T; Goodwyn D; Shoji M; Vogler WR; Sakurada K; Uehara M; Miyazaki T
    Leuk Res; 1994 Mar; 18(3):213-20. PubMed ID: 7511193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity.
    Hall CL; Wang C; Lange LA; Turley EA
    J Cell Biol; 1994 Jul; 126(2):575-88. PubMed ID: 7518470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts.
    Matsuyoshi N; Hamaguchi M; Taniguchi S; Nagafuchi A; Tsukita S; Takeichi M
    J Cell Biol; 1992 Aug; 118(3):703-14. PubMed ID: 1639852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.
    Faris M; Gaskin F; Parsons JT; Fu SM
    J Exp Med; 1994 Jun; 179(6):1923-31. PubMed ID: 7515102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ret tyrosine kinase activity by herbimycin A.
    Taniguchi M; Uehara Y; Matsuyama M; Takahashi M
    Biochem Biophys Res Commun; 1993 Aug; 195(1):208-14. PubMed ID: 8363602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of quail myoblasts transformed with a temperature sensitive mutant of Rous sarcoma virus. I. Relationship between differentiation and tyrosine kinase of src gene product.
    Kim J; Adachi T; Hirayama E; Yabubayashi T; Okada Y
    Cell Struct Funct; 1992 Aug; 17(4):237-47. PubMed ID: 1382873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism.
    Fukazawa H; Uehara Y; Murakami Y; Mizuno S; Hamada M; Takeuchi T
    FEBS Lett; 1994 Mar; 340(3):155-8. PubMed ID: 8131836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurite outgrowth stimulated by the tyrosine kinase inhibitor herbimycin A requires activation of tyrosine kinases and protein kinase C.
    Doherty P; Furness J; Williams EJ; Walsh FS
    J Neurochem; 1994 Jun; 62(6):2124-31. PubMed ID: 7514647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.